Health tech major Beurer India on expansion mode with Sourav Ganguly as brand ambassador
Beurer India, a subsidiary of German-based health and wellness technology major Beurer Gmbh, has announced the Indian cricketer and former captain Sourav Ganguly as...
Kinetic unveils UVC light-based sanitiser that kills 99.9% of coronavirus in 15 minutes
Kinetic Communications Ltd; a member of the Kinetic Group, has introduced 'UV WARRIOR', a portable disinfector that 'sanitises all daily objects and any room...
Sun Pharmaceutical declares 5-yr positive results for ILUMYA
Pharma major Sun Pharmaceutical Industries Limited has announced that one of its wholly owned subsidiaries presented positive, five-year Phase 3 data for ILUMYA (tildrakizumab-asmn)...
REME HALO inactivates levels of SARS-COV-2 by 99.9%: Zeco Aircon Group Study
Zeco in partnership with RGF Environmental group has published the results of a third-party study that claim REME HALO with photo hydro ionisation (PHI)...
Matrix Medical Network ties up with AstraZeneca
Matrix Medical Network has announced a partnership with AstraZeneca to accelerate a clinical trial in the US for AZD7442, AstraZeneca's long-acting monoclonal antibody (LAAB)...
Aster Labs unveils Digital Pathology Solution approved by USFDA
Aster Labs has introduced US FDA approved digital pathology solution at two of its facilities.
The diagnostics arm of Aster DM Healthcare, a healthcare service...
Johnson & Johnson single-dose Covid-19 vaccine gets emergency use listing by WHO
Johnson & Johnson has announced that the World Health Organization (WHO) has issued Emergency Use Listing (EUL) for its single-shot COVID-19 vaccine.
It has been...
Women’s reproductive healthcare gets boost with home blood-testing kit for fertility
Women's fertility issues received a boost, as health start-up Yesmom announced the launch of Asia's first at-home blood testing kits for female fertility, designed...
Bharat Biotech raises hopes to chase away Covid-19 as it commences Covaxin’s Phase III...
Hyderabad-based Bharat Biotech has said it has commenced Phase III trials of COVAXIN™ today (November 17, 2020).
According to the company, this exercise, conducted in...
Biohaven gives important update on phase 2/3 trial and Alzheimer’s disease program
Biohaven Pharmaceutical Holding Company Ltd has announced completed a focused analysis of the topline co-primary and key secondary data from its Phase 2/3 clinical...